The healthcare sector, working tirelessly to safeguard the health and well-being of millions on a daily basis, depends on the life-saving drugs produced by the pharmaceutical industry. Working with medical research professionals, laboratories, and universities, the pharma industry is constantly developing and testing new drugs to treat diseases previously thought to be incurable.

The global pharmaceutical manufacturing market was estimated at US $324 billion in 2020, with India’s market alone accounting for US $55 billion. In recent years, the Indian pharma sector has seen a healthy influx of foreign direct investment, including joint ventures, distribution, and co-development.

Our pharma law firm, Aarna Law, is proud to be involved with the people who help make the world a healthier place. We work with multiple generic drug manufacturers on private equity investments, and represent them in court and arbitration disputes with Big Pharma.

Our legal services within this industry are varied and extensive:

  • Advised prominent pharmaceutical companies on matters relating to technology transfers in pharmaceutical manufacturing
  • Drafted and advised on Join Development Agreements (JDA)
  • Advised on and assisted in the strategic sale and purchase of assets
  • As a lifesciences law firm, we have also represented major pharmaceutical manufacturers in shareholder disputes